Literature DB >> 10800940

Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons.

G J Brewer1, T W Wallimann.   

Abstract

The loss of ATP, which is needed for ionic homeostasis, is an early event in the neurotoxicity of glutamate and beta-amyloid (A(beta)). We hypothesize that cells supplemented with the precursor creatine make more phosphocreatine (PCr) and create larger energy reserves with consequent neuroprotection against stressors. In serum-free cultures, glutamate at 0.5-1 mM was toxic to embryonic hippocampal neurons. Creatine at >0.1 mM greatly reduced glutamate toxicity. Creatine (1 mM) could be added as late as 2 h after glutamate to achieve protection at 24 h. In association with neurotoxic protection by creatine during the first 4 h, PCr levels remained constant, and PCr/ATP ratios increased. Morphologically, creatine protected against glutamate-induced dendritic pruning. Toxicity in embryonic neurons exposed to A(beta) (25-35) for 48 h was partially prevented by creatine as well. During the first 6 h of treatment with A(beta) plus creatine, the molar ratio of PCr/ATP in neurons increased from 15 to 60. Neurons from adult rats were also partially protected from a 24-h exposure to A(beta) (25-35) by creatine, but protection was reduced in neurons from old animals. These results suggest that fortified energy reserves are able to protect neurons against important cytotoxic agents. The oral availability of creatine may benefit patients with neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800940     DOI: 10.1046/j.1471-4159.2000.0741968.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  64 in total

1.  Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria.

Authors:  Anjali Sharma; Ghareb M Soliman; Noura Al-Hajaj; Rishi Sharma; Dusica Maysinger; Ashok Kakkar
Journal:  Biomacromolecules       Date:  2011-12-16       Impact factor: 6.988

2.  Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum: evidence for transcriptional regulation.

Authors:  Wei Shen; Dianna Willis; Yanping Zhang; Uwe Schlattner; Theo Wallimann; George R Molloy
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 3.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

4.  A serum- and antioxidant-free primary culture model of mouse cortical neurons for pharmacological screen and studies of neurotrophic and neuroprotective agents.

Authors:  Xinyu Yu; Lijia An
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

Review 5.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

Authors:  Dimitrios Kapogiannis; Mark P Mattson
Journal:  Lancet Neurol       Date:  2010-12-10       Impact factor: 44.182

6.  Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.

Authors:  Isaac M Adanyeguh; Marie-Lorraine Monin; Daisy Rinaldi; Léorah Freeman; Alexandra Durr; Stéphane Lehéricy; Pierre-Gilles Henry; Fanny Mochel
Journal:  NMR Biomed       Date:  2018-01-09       Impact factor: 4.044

Review 7.  Potential future neuroprotective therapies for neurodegenerative disorders and stroke.

Authors:  Rawan Tarawneh; James E Galvin
Journal:  Clin Geriatr Med       Date:  2010-02       Impact factor: 3.076

8.  Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Authors:  Holger Lenz; Melanie Schmidt; Vivienne Welge; Thomas Kueper; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Staeb; Thomas Blatt
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

Review 9.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.